Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN116655694A enables metal-free synthesis. Delivers high purity catalysts for asymmetric reactions with reduced supply chain complexity and cost.
Novel 7-step route avoids resolution, offering cost-effective manufacturing of chiral proline derivatives for pharmaceutical intermediates.
Patent CN101228153A details a safe route to chiral tetrazoles using dialkylaluminum azides, replacing toxic tin reagents for scalable API intermediate production.
Patent CN100361971C reveals tunable L-proline catalysts for asymmetric aldol reactions, offering metal-free synthesis routes and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102397793A reveals efficient cinchona-squaramide catalysts for asymmetric reactions, offering scalable synthesis and superior stereoselectivity for pharma intermediates.
Patent CN107899611B details bifunctional catalysts combining cinchona alkaloids and porphyrins for visible-light driven asymmetric synthesis, offering greener pharmaceutical intermediate production.
Novel organocatalysts for asymmetric aldol reactions offering high ee/dr and recyclability for pharmaceutical intermediate manufacturing.
Patent CN101891668B reveals novel L-prolineamide catalysts enabling high-yield, metal-free asymmetric synthesis. Ideal for reliable pharmaceutical intermediate supplier strategies.
Patent CN111777637B details novel indole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions.